Published in

Elsevier, European Urology

DOI: 10.1016/j.eururo.2019.08.006

Links

Tools

Export citation

Search in Google Scholar

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Journal article published in 2019 by Alex P. Hoyle, Adnan Ali, Nicholas D. James ORCID, Adrian Cook, Christopher C. Parker, Johann S. de Bono ORCID, Gerhardt Attard ORCID, Simon Chowdhury, William R. Cross, David P. Dearnaley ORCID, Christopher D. Brawley, Clare Gilson, Fiona Ingleby, Silke Gillessen ORCID, Daniel M. Aebersold and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO